Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Other Non-Current Assets (2016 - 2022)

Catalyst Pharmaceuticals' Other Non-Current Assets history spans 13 years, with the latest figure at $9000.0 for Q4 2022.

  • For Q4 2022, Other Non-Current Assets changed 0.0% year-over-year to $9000.0; the TTM value through Dec 2022 reached $9000.0, changed 0.0%, while the annual FY2022 figure was $9000.0, 0.0% changed from the prior year.
  • Other Non-Current Assets reached $9000.0 in Q4 2022 per CPRX's latest filing, roughly flat from $9000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $9000.0 in Q4 2020 to a low of $8888.0 in Q1 2018.
  • Average Other Non-Current Assets over 5 years is $8938.4, with a median of $8888.0 recorded in 2018.
  • Peak YoY movement for Other Non-Current Assets: changed 0.0% in 2018, then grew 1.26% in 2020.
  • A 5-year view of Other Non-Current Assets shows it stood at $8888.0 in 2018, then changed by 0.0% to $8888.0 in 2019, then increased by 1.26% to $9000.0 in 2020, then changed by 0.0% to $9000.0 in 2021, then changed by 0.0% to $9000.0 in 2022.
  • Per Business Quant, the three most recent readings for CPRX's Other Non-Current Assets are $9000.0 (Q4 2022), $9000.0 (Q3 2022), and $9000.0 (Q2 2022).